Comparison of the Impact of Short (<1 Year) and Long-Term (≥1 Year) Clopidogrel Use Following Percutaneous Coronary Intervention on Mortality

This publication has 19 references indexed in Scilit:

• 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
  Journal of the American College of Cardiology, 2008
• Guideline Implementation Research: Exploring the Gap between Evidence and Practice in the CRUSADE Quality Improvement Initiative
  Academic Emergency Medicine, 2007
• Antiplatelet Therapy in Patients with Unstable Angina and Non–ST‐Segment‐Elevation Myocardial Infarction: Findings from the CRUSADE National Quality Improvement Initiative
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
• Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
  Journal of the American College of Cardiology, 2006
• Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With FibrinolyticsThe PCI-CLARITY Study
  JAMA, 2005
• Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
  JAMA, 2005
• Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
  Published by Elsevier ,2004
• Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
  JAMA, 2002
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
  The Lancet, 2001
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996